Brind.

Revvity is identified as a leading company in the MedTech sector.

2 reports, 1 independent Updated Jul 28

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Revvity is identified as a leading company in the MedTech sector.

Who's involved

What this event is mainly about

Revvity Medtech

Keep exploring

The entities involved

Revvity
American biotech company
- Revvity and Codexis, both healthcare companies, are currently competing against each other for market share.Sun 08:23
- Dovish remarks made on September 3, 2025, eased market concerns regarding high interest rates, involving the FED and Jerome Powell.Sun 01:44
Medtech
medical education facility founded in 2004 in Indianapolis, U.S
- Alkem Laboratories built its MedTech business from the ground up and its board thanked the CFO for strategic mandates.Thu 08:21

Related events

Manufacturers Life Insurance Company purchased a new stake in Revvity shares.Aug 27

Coverage

Newest first; wire copies grouped

Jul 28ZacksRVTY Posts Q2 Earnings & Sales Beat, Raises '25 Sales View Revvity, Inc. RVTY reported second-quarter 2025 adjusted earnings per share (EPS) of $1.18, which beat the Zacks Consensus Estimate of $1.14
Jul 26ZacksWhy Revvity (RVTY) is Poised to Beat Earnings Estimates Again If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in